Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1973 1
1977 1
1983 1
1988 1
1989 1
1990 1
1992 1
1993 1
1994 1
1995 6
1996 7
1997 5
1998 2
1999 4
2000 5
2001 7
2002 4
2003 4
2004 6
2005 2
2006 3
2007 9
2008 13
2009 14
2010 14
2011 12
2012 15
2013 18
2014 20
2015 12
2016 13
2017 11
2018 15
2019 18
2020 13
2021 22
2022 12
2023 17
2024 15

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

278 results

Results by year

Filters applied: . Clear all
Page 1
Efficacy, durability, and safety of intravitreal faricimab up to every 16 weeks for neovascular age-related macular degeneration (TENAYA and LUCERNE): two randomised, double-masked, phase 3, non-inferiority trials.
Heier JS, Khanani AM, Quezada Ruiz C, Basu K, Ferrone PJ, Brittain C, Figueroa MS, Lin H, Holz FG, Patel V, Lai TYY, Silverman D, Regillo C, Swaminathan B, Viola F, Cheung CMG, Wong TY; TENAYA and LUCERNE Investigators. Heier JS, et al. Lancet. 2022 Feb 19;399(10326):729-740. doi: 10.1016/S0140-6736(22)00010-1. Epub 2022 Jan 24. Lancet. 2022. PMID: 35085502 Clinical Trial.
TENAYA and LUCERNE: Two-Year Results from the Phase 3 Neovascular Age-Related Macular Degeneration Trials of Faricimab with Treat-and-Extend Dosing in Year 2.
Khanani AM, Kotecha A, Chang A, Chen SJ, Chen Y, Guymer R, Heier JS, Holz FG, Iida T, Ives JA, Lim JI, Lin H, Michels S, Quezada Ruiz C, Schmidt-Erfurth U, Silverman D, Singh R, Swaminathan B, Willis JR, Tadayoni R; TENAYA and LUCERNE Investigators. Khanani AM, et al. Ophthalmology. 2024 Aug;131(8):914-926. doi: 10.1016/j.ophtha.2024.02.014. Epub 2024 Feb 19. Ophthalmology. 2024. PMID: 38382813 Free article. Clinical Trial.
Laponite for biomedical applications: An ophthalmological perspective.
Rodrigo MJ, Cardiel MJ, Fraile JM, Mayoral JA, Pablo LE, Garcia-Martin E. Rodrigo MJ, et al. Among authors: pablo le. Mater Today Bio. 2023 Dec 28;24:100935. doi: 10.1016/j.mtbio.2023.100935. eCollection 2024 Feb. Mater Today Bio. 2023. PMID: 38239894 Free PMC article. Review.
Etomidate and telazol.
Pablo LS, Bailey JE. Pablo LS, et al. Vet Clin North Am Small Anim Pract. 1999 May;29(3):779-92. doi: 10.1016/s0195-5616(99)50060-0. Vet Clin North Am Small Anim Pract. 1999. PMID: 10332822 Review.
OCULAR ADVERSE EVENTS ASSOCIATED WITH MEK INHIBITORS.
Méndez-Martínez S, Calvo P, Ruiz-Moreno O, Pardiñas Barón N, Leciñena Bueno J, Gil Ruiz MDR, Pablo L. Méndez-Martínez S, et al. Among authors: pablo l. Retina. 2019 Aug;39(8):1435-1450. doi: 10.1097/IAE.0000000000002451. Retina. 2019. PMID: 30681641 Review.
Clinical Applications of Dexamethasone for Aged Eyes.
Abadia B, Calvo P, Ferreras A, Bartol F, Verdes G, Pablo L. Abadia B, et al. Among authors: pablo l. Drugs Aging. 2016 Sep;33(9):639-46. doi: 10.1007/s40266-016-0392-z. Drugs Aging. 2016. PMID: 27566619 Review.
Guidelines for treatment of chronic primary angle-closure glaucoma.
Muñoz-Negrete FJ, González-Martín-Moro J, Casas-Llera P, Urcelay-Segura JL, Rebolleda G, Ussa F, Güerri Monclús N, Méndez Hernández C, Moreno-Montañés J, Villegas Pérez MP, Pablo LE, García-Feijoó J. Muñoz-Negrete FJ, et al. Among authors: pablo le. Arch Soc Esp Oftalmol. 2015 Mar;90(3):119-38. doi: 10.1016/j.oftal.2014.09.014. Epub 2014 Nov 15. Arch Soc Esp Oftalmol. 2015. PMID: 25459683 Review. English, Spanish.
«Do Not Do» recommendations for retinopathies: A mixed consensus study.
Pablo L, Beckford CA, Martin-Delgado J, Ferro Osuna M, Fernández-Ferreiro A, Fernández Rodriguez MI, Rodriguez Cid MJ, Méndez S, Torres A, Ignacio E, Mira JJ. Pablo L, et al. Arch Soc Esp Oftalmol (Engl Ed). 2021 Nov;96(11):578-586. doi: 10.1016/j.oftale.2021.01.007. Epub 2021 Oct 17. Arch Soc Esp Oftalmol (Engl Ed). 2021. PMID: 34756279 Review.
278 results